Gulf Resources (GURE) Soars on Natural Gas Discovery

New Post Public Reply Private Reply Replies (0) Message Board
riddock57
The trading levels of Gulf Resources, Inc. (GURE) exploded in the right direction on Friday, after the company reported that it has found natural gas resources under its bromine well in Sichuan area

In 2014, the Chinese National Petroleum Corporation discovered 440.4 billion cubic meters of proven geological natural gas reserves of which 308.2 billion cubic meters is "technically recoverable" in Moxi block of An'yue field Sichuan Province. This area is very near to the region where GURE is exploring for bromine.

China continues to have a shortage of both natural gas and oil. While world prices have come down, prices in China have remained on a stable increase trend and China is still a large importer of natural gas. GURE said that the discovery of natural gas in its drilling area might bring the company into a business segment with exceptional opportunities in terms of both sales and profits.

Shares of GURE closed at $1.76, up $0.58 (or +49.15%)

GURE is a leading provider of bromine, crude salt and a portfolio of various specialty chemicals throughout China.

More about Gulf Resources, Inc. (GURE) at www.gulfresourcesinc.com

**

The price of ImmunoGen, Inc. (IMGN) stock soared $1.43 (or +23.06%) to $7.63 per share, after the biotechnology company delivered a strong operating performance on its financial results

For its second quarter fiscal 2015, IMGN posted revenues of $48.3 million, a 60.5% increase year over year, and net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million, or $0.04 per basic and diluted share in the same period the prior year, these results substantially above the Capital IQ Consensus Estimate of ($0.05) loss per share on revenues of $33.45 million for the period

For the full year fiscal 2015, IMGN expects its revenues to be between $100 million and $105 million.

IMGN develops targeted anticancer therapeutics. Its ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells; IMGN has also developed antibodies with anticancer activity of their own.

More about ImmunoGen, Inc. (IMGN) at www.immunogen.com

**

Shares of Synaptics Inc. (SYNA) jumped $8.50 (or +12.44%) to $76.81 on Friday's trading session, following the release of its financial results.

For its second quarter fiscal 2015, SYNA posted net revenue of $463.7 million, a 125% increase year over year, and non-GAAP net income of $55.8 million, or $1.46 per diluted share, compared to non-GAAP net income of $31.1 million, or $0.86 per diluted share in the same period the prior year, these results better than the Capital IQ Consensus Estimate of $1.21 earnings per share on revenues of $449.33 million for the period

For its third quarter fiscal 2015, SYNA expects its revenues to be in the range of $450 to $490 million, representing an increase of 120% to 140% year over year.

SYNA is the pioneer and leader of the human interface revolution, bringing innovative and intuitive user experiences to intelligent devices.

More about Synaptics Inc. (SYNA) at www.synaptics.com.

**

Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.

It has recently included the City of Visalia, CA ( www.visalia.crwe-pr.com ) into the CRWE Network.

As the county seat of Tulare County, in California, Visalia serves as the economic and governmental center to one of the most productive single agricultural counties in the country. Nestled in the foothills below the majestic Sierra Nevada. Visalia is the Gateway of Sequoia and Kings Canyon National Parks. Visalia has become a thriving community that takes pride in the small town feel and high quality of life that accompanies its big city amenities.

The City of Visalia had an estimated population in 2013 (U.S. Census Bureau) of 127,763, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally

The CRWE Network has reached the 1487th community website in the U.S., associated with 3456 ZIP Codes, and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer

Gulf Resources Inc. (GURE) Stock Research Links

GURE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mazu Culture Forum Unveils New Initiatives in China

Updated Category News Views 126

A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...

Continue Reading
Foxconn Spotlights AI Advancements at Tech Day 2026

Updated Category News Views 127

Foxconn's Bold Step into AI Infrastructure Foxconn, the tech giant that most folks recognize for its sheer prowess in electronics manufacturing, isn't just idling on past laurels. During the 7th annual Hon Hai Tech Day 2026, it was a showcase of fireworks that left attendees buzzing about the future of AI infrastructure and beyond. And when Foxconn says it's transforming,...

Continue Reading
Haunted Attraction Insights from the Queen of Haunts

Updated Category News Views 5

Admit it—everyone's got that one fear that sends shivers down their spine. Whether it's the slithering scales of a snake or the manic laughter of a clown, those phobias are what make haunted attractions such a hit for thrillseekers across the country. Amber Arnett-Bequeaith, the so-called Queen of Haunts, knows a thing or two about turning those fears into unforgettable...

Continue Reading
European Doctors Explore Chinese Aesthetic Innovations

Updated Category News Views 39

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Continue Reading
Gooru AI Unveils Platform to Scale Human Expertise

Updated Category News Views 67

A New Wave of AI-Powered Solutions Hot off the press, Gooru AI's recent shindig in the heart of Dallas aimed to showcase something they call 'Digital Goorus.' Now that might sound like a newage tech gimmick but peel back the layers and you find an ambitious attempt to let folks spread their smarts without having to be everywhere all at once. Imagine being able to crack...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 69

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 172

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
MediaGo Wins Big in France with Optimized Strategies

Updated Category News Views 75

MediaGo's Winning Edge in Advertising Shake the dust off your boots and get ready for a tale of triumph straight out of San Francisco. MediaGo, the top dog in global intelligent advertising platforms, just added a couple of shiny awards to its trophy case thanks to the prestigious Les Cas d'OR 2026 in France. And let me tell ya, these wins aren't just about some pretty...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 71

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 33

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Consumer Product Risks: Insights from Legal Experts

Updated Category News Views 131

Investigation into Defective Consumer Products The Law Offices of Jason Turchin is currently investigating various claims related to defective consumer products that can potentially harm individuals. These products include commonly used items such as space heaters and HVAC systems, as well as kitchen equipment like coffee makers and pressure cookers. Each of these items...

Continue Reading
Nauticos Takes Bold Steps Toward Uncovering Earhart's Mystery

Updated Category News Views 303

Nauticos Aims to Solve a Historic Mystery Nauticos, a leader in deep-sea exploration and historical research, has announced an exciting new expedition to locate Amelia Earhart's Lockheed Electra. This groundbreaking mission is fueled by proprietary data that pinpoints the likely resting place of the iconic aircraft. The research advances our understanding of where Earhart...

Continue Reading
Equitable Bank Achieves Historic $300 Million Deposit Note Success

Updated Category News Views 197

Equitable Bank Closes Impressive $300 Million Deposit Note Issuance Equitable Bank, Canada's Challenger Bank™, has successfully closed a monumental $300 million floating rate deposit note issuance. This remarkable achievement marks the tightest spread on record for deposit notes of a similar term issued by the bank. The overwhelming response from investors demonstrates...

Continue Reading
Exploring the Long-Term Gains of Sprouts Farmers Market Stock

Updated Category News Views 98

Understanding the Growth of Sprouts Farmers Market Stock Over the last decade, Sprouts Farmers Market (NASDAQ: SFM) has demonstrated remarkable growth, consistently surpassing market returns by an impressive 3.05% annually. With average annual returns reaching 14.93%, this company's performance is a topic of great interest among investors. Initial Investment Insights...

Continue Reading
Anticipating Royalty Pharma's First Quarter 2025 Financial Results

Updated Category News Views 119

Upcoming Financial Results Announcement Royalty Pharma plc (Nasdaq: RPRX) is gearing up to share its financial journey for the first quarter of 2025 on May 8, 2025. As one of the largest buyers of biopharmaceutical royalties, the firm is set to unveil its latest financial results early in the day, prior to the opening of U.S. markets. This announcement will give investors...

Continue Reading